Breakthrough drug trial aims to cure chronic hepatitis b
NCT ID NCT05630820
Summary
This large, late-stage study is testing whether a drug called bepirovirsen can provide a 'functional cure' for people with chronic Hepatitis B. It involves 857 participants who are already on standard medication. The main goal is to see if the treatment can suppress the virus to undetectable levels and allow patients to safely stop all medications long-term.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Centreville, Alabama, 35042, United States
-
GSK Investigational Site
Los Angeles, California, 90033, United States
-
GSK Investigational Site
San Francisco, California, 94115, United States
-
GSK Investigational Site
San Francisco, California, 94121, United States
-
GSK Investigational Site
Colorado Springs, Colorado, 80907, United States
-
GSK Investigational Site
Ft. Pierce, Florida, 34982, United States
-
GSK Investigational Site
Miami, Florida, 33136, United States
-
GSK Investigational Site
Glen Burnie, Maryland, 21061, United States
-
GSK Investigational Site
Minneapolis, Minnesota, 55404, United States
-
GSK Investigational Site
Philadelphia, Pennsylvania, 19104, United States
-
GSK Investigational Site
Denison, Texas, 75020, United States
-
GSK Investigational Site
Seattle, Washington, 98104, United States
-
GSK Investigational Site
Buenos Aires, 1023, Argentina
-
GSK Investigational Site
Buenos Aires, C1425AGC, Argentina
-
GSK Investigational Site
Ciudad Autonoma de Bueno, C1056ABI, Argentina
-
GSK Investigational Site
Santa Fe, 3000, Argentina
-
GSK Investigational Site
Westmead, New South Wales, 2145, Australia
-
GSK Investigational Site
Herston, Queensland, 4029, Australia
-
GSK Investigational Site
Box Hill, Victoria, 3128, Australia
-
GSK Investigational Site
Fitzroy, Victoria, 3065, Australia
-
GSK Investigational Site
Botucatu, 18618-686, Brazil
-
GSK Investigational Site
Fortaleza, 60430-372, Brazil
-
GSK Investigational Site
Nova Iguaçu, 26030-380, Brazil
-
GSK Investigational Site
Porto Alegre, 90020-090, Brazil
-
GSK Investigational Site
Porto Alegre, 90035003, Brazil
-
GSK Investigational Site
Rio de Janeiro, 21045-900, Brazil
-
GSK Investigational Site
Salvador, 40110160, Brazil
-
GSK Investigational Site
Vitória, 29043260, Brazil
-
GSK Investigational Site
Plovdiv, 4002, Bulgaria
-
GSK Investigational Site
Sliven, 8800, Bulgaria
-
GSK Investigational Site
Sofia, 1797, Bulgaria
-
GSK Investigational Site
Varna, 9020, Bulgaria
-
GSK Investigational Site
Calgary, Alberta, T2N 4N1, Canada
-
GSK Investigational Site
Edmonton, Alberta, T6G 2B7, Canada
-
GSK Investigational Site
Edmonton, Alberta, T6G 2X8, Canada
-
GSK Investigational Site
Halifax, Nova Scotia, B3H 2Y9, Canada
-
GSK Investigational Site
Toronto, Ontario, M6H 3M1, Canada
-
GSK Investigational Site
Montreal, Quebec, H2L 4E9, Canada
-
GSK Investigational Site
Montreal, Quebec, H2L 4P9, Canada
-
GSK Investigational Site
Regina, Saskatchewan, S4P 0W5, Canada
-
GSK Investigational Site
Beijing, 100015, China
-
GSK Investigational Site
Beijing, 100032, China
-
GSK Investigational Site
Changchun, 130021, China
-
GSK Investigational Site
Chengdu, 610072, China
-
GSK Investigational Site
Chongqing, 400042, China
-
GSK Investigational Site
Guangzhou, 510515, China
-
GSK Investigational Site
Guangzhou, 510630, China
-
GSK Investigational Site
Hangzhou, 310000, China
-
GSK Investigational Site
Hangzhou, 310003, China
-
GSK Investigational Site
Hefei, 230022, China
-
GSK Investigational Site
Kunming, 650021, China
-
GSK Investigational Site
Liuchow, China
-
GSK Investigational Site
Nanjing, 210003, China
-
GSK Investigational Site
Shanghai, 200025, China
-
GSK Investigational Site
Shanghai, 200052, China
-
GSK Investigational Site
Shenzhen, 518023, China
-
GSK Investigational Site
Taiyuan, 030001, China
-
GSK Investigational Site
Tianjin, 300000, China
-
GSK Investigational Site
Ürümqi, 830054, China
-
GSK Investigational Site
Wuhan, 430022, China
-
GSK Investigational Site
Xi'an, 710061, China
-
GSK Investigational Site
Xiamen, 361015, China
-
GSK Investigational Site
Zhengzhou, 450000, China
-
GSK Investigational Site
Zunyi, 563114, China
-
GSK Investigational Site
Créteil, 94010, France
-
GSK Investigational Site
Grenoble, 38043, France
-
GSK Investigational Site
Limoges, 87042, France
-
GSK Investigational Site
Lyon, 69317, France
-
GSK Investigational Site
Paris, 75651, France
-
GSK Investigational Site
Rouen, 76031, France
-
GSK Investigational Site
Toulouse, 31059, France
-
GSK Investigational Site
Frankfurt, 60329, Germany
-
GSK Investigational Site
Frankfurt, 60596, Germany
-
GSK Investigational Site
Hamburg, 20146, Germany
-
GSK Investigational Site
Hanover, 30625, Germany
-
GSK Investigational Site
Athens, 115 27, Greece
-
GSK Investigational Site
Heraklion Crete, 715 00, Greece
-
GSK Investigational Site
Thessaloniki, 54642, Greece
-
GSK Investigational Site
Szeged, 6725, Hungary
-
GSK Investigational Site
Székesfehérvár, 8000, Hungary
-
GSK Investigational Site
Zalaegerszeg, Hungary
-
GSK Investigational Site
Ahmedabad, 380009, India
-
GSK Investigational Site
Chennai, 600035, India
-
GSK Investigational Site
Kanpur, 208002, India
-
GSK Investigational Site
Kochi, 682026, India
-
GSK Investigational Site
Kolkata, 700150, India
-
GSK Investigational Site
Kolkata, India
-
GSK Investigational Site
Mumbai, 400012, India
-
GSK Investigational Site
Mumbai, 400022, India
-
GSK Investigational Site
Nagpur, 441108, India
-
GSK Investigational Site
New Delhi, 110029, India
-
GSK Investigational Site
New Delhi, 110060, India
-
GSK Investigational Site
New Delhi, 110070, India
-
GSK Investigational Site
Pune, 411001, India
-
GSK Investigational Site
Raipur, India
-
GSK Investigational Site
Secunderabad, 500003, India
-
GSK Investigational Site
Milan, 20157, Italy
-
GSK Investigational Site
Napoli, 80131, Italy
-
GSK Investigational Site
Padua, 35128, Italy
-
GSK Investigational Site
Palermo, 90127, Italy
-
GSK Investigational Site
Pisa, 56124, Italy
-
GSK Investigational Site
Roma, 00133, Italy
-
GSK Investigational Site
Sassari, 07100, Italy
-
GSK Investigational Site
Torino, 10126, Italy
-
GSK Investigational Site
Fukui, 918-8503, Japan
-
GSK Investigational Site
Hiroshima, 730-8619, Japan
-
GSK Investigational Site
Hokkaido, 006-8555, Japan
-
GSK Investigational Site
Hokkaido, 060-8648, Japan
-
GSK Investigational Site
Hokkaido, 062-8618, Japan
-
GSK Investigational Site
Ishikawa, 920-8650, Japan
-
GSK Investigational Site
Kagawa, 760-8557, Japan
-
GSK Investigational Site
Kumamoto, 860-8556, Japan
-
GSK Investigational Site
Nagasaki, 856-8562, Japan
-
GSK Investigational Site
Nara, 634-8522, Japan
-
GSK Investigational Site
Niigata, 950-1104, Japan
-
GSK Investigational Site
Osaka, 565-0871, Japan
-
GSK Investigational Site
Tokyo, 113-8603, Japan
-
GSK Investigational Site
Yamaguchi, 750-0061, Japan
-
GSK Investigational Site
Yamanashi, 409-3898, Japan
-
GSK Investigational Site
Johor Bahru, 80100, Malaysia
-
GSK Investigational Site
Kota Bharu Kelantan, Malaysia
-
GSK Investigational Site
Kota Kinabalu, Malaysia
-
GSK Investigational Site
Kuala Lumpur, 59100, Malaysia
-
GSK Investigational Site
Kuala Terengganu, 20400, Malaysia
-
GSK Investigational Site
Kuantan, 25100, Malaysia
-
GSK Investigational Site
Aguascalientes, 20010, Mexico
-
GSK Investigational Site
Auckland, 1023, New Zealand
-
GSK Investigational Site
Papatoetoe Auckland, 2025, New Zealand
-
GSK Investigational Site
Panama City, Panama
-
GSK Investigational Site
Cebu City, 6000, Philippines
-
GSK Investigational Site
Makati City, 1229, Philippines
-
GSK Investigational Site
Pasig, 1605, Philippines
-
GSK Investigational Site
Silang, 4118, Philippines
-
GSK Investigational Site
Gdansk, 80-405, Poland
-
GSK Investigational Site
Mysłowice, 41-400, Poland
-
GSK Investigational Site
Żychlin, 62-571, Poland
-
GSK Investigational Site
Bucharest, 020475, Romania
-
GSK Investigational Site
Bucharest, 030303, Romania
-
GSK Investigational Site
Cluj-Napoca, 400348, Romania
-
GSK Investigational Site
Constanța, 900709, Romania
-
GSK Investigational Site
Galati, 800179, Romania
-
GSK Investigational Site
Oradea, 410469, Romania
-
GSK Investigational Site
Ansan, 15355, South Korea
-
GSK Investigational Site
Incheon, 405-760, South Korea
-
GSK Investigational Site
Pusan, 49241, South Korea
-
GSK Investigational Site
Seoul, 03312, South Korea
-
GSK Investigational Site
Seoul, 05505, South Korea
-
GSK Investigational Site
Ulsan, 44033, South Korea
-
GSK Investigational Site
Alcorcon Madrid, Spain
-
GSK Investigational Site
Badajoz, 06080, Spain
-
GSK Investigational Site
Granada, 18016, Spain
-
GSK Investigational Site
Madrid, 28006, Spain
-
GSK Investigational Site
Madrid, 28032, Spain
-
GSK Investigational Site
Madrid, 28046, Spain
-
GSK Investigational Site
Sabadell Barcelona, 08208, Spain
-
GSK Investigational Site
Seville, 41013, Spain
-
GSK Investigational Site
Valencia, 46026, Spain
-
GSK Investigational Site
Valladolid, 47012, Spain
-
GSK Investigational Site
Zaragoza, 50009, Spain
-
GSK Investigational Site
Kaohsiung City, 824, Taiwan
-
GSK Investigational Site
Taichung, 404, Taiwan
-
GSK Investigational Site
Tainan, 704, Taiwan
-
GSK Investigational Site
Taipei, 100, Taiwan
-
GSK Investigational Site
Chiang Mai, 50200, Thailand
-
GSK Investigational Site
Ankara, 06590, Turkey (Türkiye)
-
GSK Investigational Site
Istanbul, 34010, Turkey (Türkiye)
-
GSK Investigational Site
Izmir, 35100, Turkey (Türkiye)
-
GSK Investigational Site
Liverpool, L7 8XP, United Kingdom
-
GSK Investigational Site
London, WC1E 6JB, United Kingdom
-
GSK Investigational Site
Middlesbrough, TS4 3BW, United Kingdom
-
GSK Investigational Site
Newcastle upon Tyne, NE7 7DN, United Kingdom